Water → HCID 22285585, 화합물
반응식
[H-].[Al+3].[Li+].[H-].[H-].[H-].Cl.[CH3:8][C:9]1[CH:14]=[CH:13][C:12]([N:15]2[CH2:20][CH2:19][NH:18][CH2:17][CH2:16]2)=[CH:11][CH:10]=1.[Cl:21][C:22]1[CH:27]=[C:26]([Cl:28])[CH:25]=[CH:24][C:23]=1[C:29]1[N:30]([C:39]2[CH:44]=[CH:43][C:42]([Cl:45])=[CH:41][CH:40]=2)[CH:31]=[C:32]([C:34](OCC)=O)[N:33]=1.O>C1COCC1>[Cl:45][C:42]1[CH:41]=[CH:40][C:39]([N:30]2[CH:31]=[C:32]([CH2:34][N:18]3[CH2:19][CH2:20][N:15]([C:12]4[CH:11]=[CH:10][C:9]([CH3:8])=[CH:14][CH:13]=4)[CH2:16][CH2:17]3)[N:33]=[C:29]2[C:23]2[CH:24]=[CH:25][C:26]([Cl:28])=[CH:27][C:22]=2[Cl:21])=[CH:44][CH:43]=1참가 물질
실험 절차
To a suspension of lithium aluminum hydride (21 mg, 0.54 mmol) in THF (2 mL), 1-(4-methylphenyl)piperazine hydrochloride (32 mg, 0.13 mmol) was added. After 10 minutes, a solution of ethyl 2-(2,4-dichlorophenyl)-1-(4-chlorophenyl)-1H-imidazole-4-carboxylate (39 mg, 0.1 mmol) in THF (2 mL) was added dropwise. The reaction mixture was stirred for 10 minutes, and diluted by water. The organic layer was dried over MgSO4, filtered, and concentrated. The residue was purified by HPLC (YMC-packed Pro C18 20×150 mm column, 10-90% CH3CN in H2O/TFA, 25 mL/min) to give the product 1-{[1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-1H-imidazol-4-yl]methyl}-4-(4-methylphenyl)-piperazine (1.4 mg, 2% yield): LC-MS m/z 511.1 (MH+), retention time 2.94 min (method 1). 1H NMR (300 MHz, CDCl3) δ: 2.29 (3H, s), 3.42-3.49 (8H, br), 4.39 (2H, s), 6.85-7.41 (11H, m), 7.54 (1H, s).
후처리
- additionwas added
- dry with materialThe organic layer was dried over MgSO4
- filtrationfiltered
- concentrationconcentrated
- customThe residue was purified by HPLC (YMC-packed Pro C18 20×150 mm column, 10-90% CH3CN in H2O/TFA, 25 mL/min)
출처 및 근거
- ORD 기록
- ord-8e0e02a126db44309d732372b093505c
- 출처 데이터셋
- uspto-grants-2005_11
- 특허 번호
- US06960601B2
반응 노트
불러오는 중…